Nationwide Fund Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-16,994
| Closed | -$1.66M | – | 3433 |
|
|
2015
Q1 | $1.66M | Buy |
16,994
+774
| +5% | +$75.5K | 0.01% | 1596 |
|
|
2014
Q4 | $1.51M | Sell |
16,220
-175
| -1% | -$16.2K | 0.01% | 1581 |
|
|
2014
Q3 | $1.13M | Sell |
16,395
-39
| -0.2% | -$2.68K | ﹤0.01% | 1763 |
|
|
2014
Q2 | $1.72M | Buy |
16,434
+1,165
| +8% | +$122K | 0.01% | 1557 |
|
|
2014
Q1 | $1.27M | Buy |
15,269
+404
| +3% | +$33.5K | 0.01% | 1614 |
|
|
2013
Q4 | $962K | Buy |
14,865
+1,308
| +10% | +$84.6K | ﹤0.01% | 1892 |
|
|
2013
Q3 | $858K | Sell |
13,557
-18,052
| -57% | -$1.14M | ﹤0.01% | 1914 |
|
|
2013
Q2 | $1.33M | Buy |
+31,609
| New | +$1.33M | 0.01% | 1539 |
|